Home > Insider Trading > Filing (0001437749-20-011868)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
946486	Windtree Therapeutics Inc	WINT	Biological Products, (No Disgnostic Substances) (2836)	943171943

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573160	James Huang	C/O Windtree Therapeutics, Inc. 2600 Kelly Road, Suite 100 Warrington PA 18976		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-22	275,862	$7.25	2,336,853	No	4	P	Indirect	Via Panacea Venture Healthcare Fund I L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Via Panacea Venture Healthcare Fund I L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants	Acquisiton	2020-05-22	275,862	$0.00	275,862	$7.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
275,862	2020-05-22	2025-05-22	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	70,281	Indirect	Via Rui Jin (HK) Consulting Management Company Limited
Common Stock	7,800	Direct

Footnotes

Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020.
The Reporting Person is a Director of Panacea Venture Healthcare Fund GP I L.P. The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein.
The Reporting Person is a Director of Rui Jin (HK) Consulting Management Company Limited.
Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above.